tirzepatide approval canada Eli Lilly cuts price of diabetes, weight-loss drugs in Canada, Globe and Mail reports 🇨🇦 Health Canada has approved

Alternative Explanations and Limitations Although the temporal association suggests a robust response to low-dose tirzepatide, several alternative explanations must be considered

Key takeaways Tirzepatide usually starts at a low weekly dose, then increases in small steps no sooner than every 4 weeks, based on response and tolerability

The SELECT cardiovascular outcomes trial (N=17,604), published in NEJM 2023 (DOI: 10.1056/NEJMoa2307563), demonstrated a 20% reduction in major adverse cardiovascular events (MACE) -- the composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke -- in overweight or obese adults without diabetes

Titration is the process of starting with a very low dose and gradually increasing it over several months

Manganese is involved in the function of many enzymes in the body